Literature DB >> 7257056

Antihistamines as prophylaxis against side reactions to intravenous fluorescein.

P P Ellis, M Schoenberger, M A Rendi.   

Abstract

Systemic antihistamines were administered prior to dye injection in 50 patients undergoing fluorescein angiography. The patients were monitored for side effects. Venous blood samples were obtained before and at three, ten and thirty minutes after intravenous administration of sodium fluorescein and analyzed for histamine levels. Three patients (6%) developed minor side effects of nausea or dizziness; this compares to an incidence of 21% in a previous series of patients from our institution untreated with antihistamines. A three-fold increase in plasma histamine levels occurred in 28% of patients following fluorescein and antihistamine injection; this compares with a 26% incidence of increase in plasma histamine in patients receiving fluorescein without antihistamines (as determined in a previous study). Prophylactic antihistamines should be considered in patients undergoing fluorescein angiography if they have a history of previous allergies or side reactions during prior fluorescein studies. However, complete prophylaxis against severe side reactions to fluorescein injections is not assured with antihistamines.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7257056      PMCID: PMC1312139     

Source DB:  PubMed          Journal:  Trans Am Ophthalmol Soc        ISSN: 0065-9533


  30 in total

1.  Efficacy of intravenous pretesting and antihistamine prophylaxis in radiocontrast media--sensitive patients.

Authors:  M W Yocum; A M Heller; R I Abels
Journal:  J Allergy Clin Immunol       Date:  1978-11       Impact factor: 10.793

2.  The vagus reaction as a possible cause of severe complications of radiological procedures.

Authors:  E J Andrews
Journal:  Radiology       Date:  1976-10       Impact factor: 11.105

3.  Adverse reaction to intravenous fluorescein: evidence for sex difference.

Authors:  G S Greene; L W Bell; R A Hitching; G L Spaeth
Journal:  Ann Ophthalmol       Date:  1976-05

4.  Effective differences in the formulation of intravenous fluorescein and related side effects.

Authors:  L A Yannuzzi; J Justice; H A Baldwin
Journal:  Am J Ophthalmol       Date:  1974-08       Impact factor: 5.258

5.  Definition and antagonism of histamine H 2 -receptors.

Authors:  J W Black; W A Duncan; C J Durant; C R Ganellin; E M Parsons
Journal:  Nature       Date:  1972-04-21       Impact factor: 49.962

6.  Benadryl and the IVP reaction.

Authors:  D F Gates; F E Ceccarelli
Journal:  J Urol       Date:  1972-10       Impact factor: 7.450

7.  Anaphylactoid reaction to intravenously administered fluorescein.

Authors:  F G LaPiana; R Penner
Journal:  Arch Ophthalmol       Date:  1968-02

8.  Severe adverse reactions to contrast media: a simplified means of recognition and treatment.

Authors:  E J Andrews
Journal:  South Med J       Date:  1977-12       Impact factor: 0.954

9.  Acute reactions to urographic contrast media.

Authors:  P Davies; M B Roberts; J Roylance
Journal:  Br Med J       Date:  1975-05-24

10.  Severe anaphylactoid reaction to radiographic contrast media. Recurrences despites premedication with diphenhydramine and prednisone.

Authors:  J S Madowitz; M J Schweiger
Journal:  JAMA       Date:  1979-06-29       Impact factor: 56.272

View more
  3 in total

1.  "Guidance of macular laser photocoagulation: is fluorescein angiography still needed?".

Authors:  Roberto Gallego-Pinazo; Manuel Díaz-Llopis; Rosa Dolz-Marco; Sebastian Martínez-Castillo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-01-05       Impact factor: 3.117

2.  Case Report of Bullous Pemphigoid following Fundus Fluorescein Angiography.

Authors:  Goktug Demirci; Gulsen Tukenmez Demirci; Gokhan Gulkilik
Journal:  Case Rep Ophthalmol       Date:  2010-05-12

3.  Macular laser photocoagulation guided by spectral-domain optical coherence tomography versus fluorescein angiography for diabetic macular edema.

Authors:  Roberto Gallego-Pinazo; Ana Marina Suelves-Cogollos; Rosa Dolz-Marco; J Fernando Arevalo; Salvador García-Delpech; J Luis Mullor; Manuel Díaz-Llopis
Journal:  Clin Ophthalmol       Date:  2011-05-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.